We are live on ! Find out more
HI

Humankind Investments Portfolio holdings

AUM $175M
1-Year Est. Return 14.3%
This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
AUM
$395M
AUM Growth
+$118M
Cap. Flow
+$125M
Cap. Flow %
31.74%
Top 10 Hldgs %
64.17%
Holding
156
New
15
Increased
70
Reduced
60
Closed
4

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.95M
2
INTC icon
Intel
INTC
+$282K
3
LEN.B icon
Lennar Class B
LEN.B
+$224K
4
CTLT
CATALENT, INC.
CTLT
+$221K
5
DVA icon
DaVita
DVA
+$204K

Sector Composition

Rank Sector Weight
1 Technology 12.75%
2 Healthcare 12.24%
3 Consumer Staples 5.17%
4 Communication Services 2.96%
5 Materials 2.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPQ icon
51
HP
HPQ
$27.5B
$1.1M 0.28%
33,759
+829
+3% +$29.8K
FMC icon
52
FMC
FMC
$1.33B
$1.07M 0.27%
21,961
+3,833
+21% +$224K
JPM icon
53
JPMorgan Chase
JPM
$950B
$1.07M 0.27%
4,446
-439
-9% -$102K
JNJ icon
54
Johnson & Johnson
JNJ
$625B
$1.04M 0.26%
7,225
-12,573
-64% -$1.95M
AGCO icon
55
AGCO
AGCO
$7.2B
$1.02M 0.26%
10,918
-10
-0.1% -$968
AMZN icon
56
Amazon
AMZN
$2.96T
$991K 0.25%
4,518
-424
-9% -$86.7K
REGN icon
57
Regeneron Pharmaceuticals
REGN
$80.8B
$925K 0.23%
1,298
+498
+62% +$418K
CMCSA icon
58
Comcast
CMCSA
$90B
$916K 0.23%
24,403
-725
-3% -$30.1K
DHR icon
59
Danaher
DHR
$144B
$907K 0.23%
3,952
+700
+22% +$172K
DGX icon
60
Quest Diagnostics
DGX
$26.3B
$894K 0.23%
5,928
-94
-2% -$14.6K
VRTX icon
61
Vertex Pharmaceuticals
VRTX
$126B
$832K 0.21%
2,067
+152
+8% +$70.5K
IQV icon
62
IQVIA
IQV
$39.3B
$823K 0.21%
4,190
+970
+30% +$205K
SJM icon
63
J.M. Smucker
SJM
$12.8B
$813K 0.21%
7,386
+1,038
+16% +$119K
BAC icon
64
Bank of America
BAC
$442B
$764K 0.19%
17,378
-2,250
-11% -$99K
DMC
65
Del Monte Corp
DMC
$1.45B
$740K 0.19%
22,272
-3,840
-15% -$123K
INGR icon
66
Ingredion
INGR
$6.58B
$728K 0.18%
5,292
-179
-3% -$25.2K
MCK icon
67
McKesson
MCK
$101B
$705K 0.18%
1,237
-77
-6% -$43.1K
ZBH icon
68
Zimmer Biomet
ZBH
$18.4B
$694K 0.18%
6,571
+262
+4% +$28.1K
C icon
69
Citigroup
C
$226B
$651K 0.16%
9,246
-687
-7% -$46.3K
ELV icon
70
Elevance Health
ELV
$85.5B
$625K 0.16%
1,695
+505
+42% +$211K
WFC icon
71
Wells Fargo
WFC
$264B
$616K 0.16%
8,767
-2,428
-22% -$166K
CVS icon
72
CVS Health
CVS
$122B
$613K 0.16%
13,655
+1,621
+13% +$90.9K
PEP icon
73
PepsiCo
PEP
$190B
$604K 0.15%
3,969
+468
+13% +$76.7K
MRNA icon
74
Moderna
MRNA
$23.6B
$600K 0.15%
14,427
+8,638
+149% +$413K
IBB icon
75
iShares Biotechnology ETF
IBB
$9.77B
$595K 0.15%
4,500

Similar funds

Humankind Investments's Q4 2024 Portfolio in Review

As of Q4 2024, Humankind Investments held 156 positions worth $395M, up 43% from $277M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Humankind Investments deployed $125M of net new capital in Q4 2024, opening 15 new positions and adding to 70 existing holdings. Its largest new stake was Invesco QQQ Trust: 86,575 shares worth $44.3M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.95M trimmed.

  • Humankind Investments's largest Q4 2024 buy was Invesco QQQ Trust: 86,575 shares worth $44.3M.
  • Humankind Investments added most to Humankind US Stock ETF in Q4 2024, an estimated $858K increase.
  • Humankind Investments's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $1.95M.
  • Humankind Investments fully exited Lennar Class B in Q4 2024, selling an estimated $224K.
  • Humankind Investments's ten largest holdings make up 64% of its $395M portfolio in Q4 2024.
  • Humankind Investments opened 15 new positions and closed 4 in Q4 2024.
  • Humankind Investments's portfolio value rose 43% quarter-over-quarter to $395M.

Based on Humankind Investments's 13F filing for Q4 2024, filed 14 Feb 2025.